Undecided on this one, Pfizer CEO says the corporate is ready to distribute “tons of of hundreds of doses,
- the agency is more likely to have the important thing information from its late-stage trial by the top of October
- if FDA approval is secured the corporate is ready
Weekend feedback from the top of the corporate.
100s of 1,000s would not actually lower it. It a begin I assume.
- On Saturday, Pfizer submitted a proposal to the FDA to develop the late-stage trial to incorporate as much as 44,000 individuals (from its earlier goal of 30,000)